|
1
|
Leontieva OV and Blagosklonny MV:
Yeast-like chronological senescence in mammalian cells: Phenomenon,
mechanism and pharmacological suppression. Aging (Albany, NY).
3:1078–1091. 2011. View Article : Google Scholar
|
|
2
|
Rubin H: Multistage carcinogenesis in cell
culture. Dev Biol (Basel). 106:61–66; discussion 67, 143–160.
2001.
|
|
3
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Piret JP, Mottet D, Raes M and Michiels C:
CoCl2, a chemical inducer of hypoxia-inducible factor-1,
and hypoxia reduce apoptotic cell death in hepatoma cell line
HepG2. Ann NY Acad Sci. 973:443–447. 2002. View Article : Google Scholar
|
|
5
|
Semenza GL: HIF-1: mediator of
physiological and patho-physiological responses to hypoxia. J Appl
Physiol (1985). 88:1474–1480. 2000.
|
|
6
|
Lee KA, Roth RA and LaPres JJ: Hypoxia,
drug therapy and toxicity. Pharmacol Ther. 113:229–246. 2007.
View Article : Google Scholar
|
|
7
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rankin EB and Giaccia AJ: The role of
hypoxia-inducible factors in tumorigenesis. Cell Death Differ.
15:678–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rofstad EK and Danielsen T:
Hypoxia-induced metastasis of human melanoma cells: Involvement of
vascular endothelial growth factor-mediated angiogenesis. Br J
Cancer. 80:1697–1707. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kothari S, Cizeau J, McMillan-Ward E,
Israels SJ, Bailes M, Ens K, Kirshenbaum LA and Gibson SB: BNIP3
plays a role in hypoxic cell death in human epithelial cells that
is inhibited by growth factors EGF and IGF. Oncogene. 22:4734–4744.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki H, Tomida A and Tsuruo T:
Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of
p53-dependent apoptosis during hypoxia. Oncogene. 20:5779–5788.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tafani M, Schito L, Anwar T, Indelicato M,
Sale P, Di Vito M, Morgante E, Beraldi R, Makovec F, Letari O, et
al: Induction of autophagic cell death by a novel molecule is
increased by hypoxia. Autophagy. 4:1042–1053. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Scarlatti F, Granata R, Meijer AJ and
Codogno P: Does autophagy have a license to kill mammalian cells?
Cell Death Differ. 16:12–20. 2009. View Article : Google Scholar
|
|
14
|
Bursch W, Karwan A, Mayer M, Dornetshuber
J, Fröhwein U, Schulte-Hermann R, Fazi B, Di Sano F, Piredda L,
Piacentini M, et al: Cell death and autophagy: Cytokines, drugs,
and nutritional factors. Toxicology. 254:147–157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Bosch-Marce M, Shimoda LA, Tan
YS, Baek JH, Wesley JB, Gonzalez FJ and Semenza GL: Mitochondrial
autophagy is an HIF-1-dependent adaptive metabolic response to
hypoxia. J Biol Chem. 283:10892–10903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ou XM, Chen K and Shih JC: Monoamine
oxidase A and repressor R1 are involved in apoptotic signaling
pathway. Proc Natl Acad Sci USA. 103:10923–10928. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Izuishi K, Kato K, Ogura T, Kinoshita T
and Esumi H: Remarkable tolerance of tumor cells to nutrient
deprivation: Possible new biochemical target for cancer therapy.
Cancer Res. 60:6201–6207. 2000.PubMed/NCBI
|
|
18
|
Piret JP, Lecocq C, Toffoli S, Ninane N,
Raes M and Michiels C: Hypoxia and CoCl2 protect HepG2
cells against serum deprivation- and t-BHP-induced apoptosis: A
possible anti-apoptotic role for HIF-1. Exp Cell Res. 295:340–349.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heyman SN, Leibowitz D, Mor-Yosef Levi I,
Liberman A, Eisenkraft A, Elcalai R, Khamaisi M and Rosenberger C:
Adaptive response to hypoxia and remote ischemia preconditioning: A
new HIF era in clinical medicine. Acta Physiol (Oxf). Oct
9–2015.(Epub ahead of print).
|
|
20
|
Hirst DG and Wood PJ: The adaptive
response of mouse tumours to anaemia and retransfusion. Int J
Radiat Biol Relat Stud Phys Chem Med. 51:597–609. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Acker T and Plate KH: A role for hypoxia
and hypoxia-inducible transcription factors in tumor physiology. J
Mol Med Berl. 80:562–575. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu SI, Yang CM, Sim KG, Hentschel DM,
O'Leary E and Bonventre JV: TRIP-Br: A novel family of PHD zinc
finger- and bromodomain-interacting proteins that regulate the
transcriptional activity of E2F-1/DP-1. EMBO J. 20:2273–2285. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sim KG, Zang Z, Yang CM, Bonventre JV and
Hsu SI: TRIP-Br links E2F to novel functions in the regulation of
cyclin E expression during cell cycle progression and in the
maintenance of genomic stability. Cell Cycle. 3:1296–1304. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sim KG, Cheong JK and Hsu SI: The TRIP-Br
family of transcriptional regulators is essential for the execution
of cyclin E-mediated cell cycle progression. Cell Cycle.
5:1111–1115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong SW, Kim CJ, Park WS, Shin JS, Lee SD,
Ko SG, Jung SI, Park IC, An SK, Lee WK, et al: p34SEI-1 inhibits
apoptosis through the stabilization of the X-linked inhibitor of
apoptosis protein: p34SEI-1 as a novel target for anti-breast
cancer strategies. Cancer Res. 69:741–746. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Muscarella P, Joo SH, Knobloch TJ,
Melvin WS, Weghorst CM and Tsai MD: Dissection of CDK4-binding and
transactivation activities of p34(SEI-1) and comparison between
functions of p34(SEI-1) and p16(INK4A). Biochemistry.
44:13246–13256. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sugimoto M, Nakamura T, Ohtani N, Hampson
L, Hampson IN, Shimamoto A, Furuichi Y, Okumura K, Niwa S, Taya Y,
et al: Regulation of CDK4 activity by a novel CDK4-binding protein,
p34(SEI-1). Genes Dev. 13:3027–3033. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liew CW, Boucher J, Cheong JK, Vernochet
C, Koh HJ, Mallol C, Townsend K, Langin D, Kawamori D, Hu J, et al:
Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis
and oxidative metabolism, prevents diet-induced obesity and insulin
resistance. Nat Med. 19:217–226. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fernandez-Marcos PJ, Pantoja C,
Gonzalez-Rodriguez A, Martin N, Flores JM, Valverde AM, Hara E and
Serrano M: Normal proliferation and tumorigenesis but impaired
pancreatic function in mice lacking the cell cycle regulator sei1.
PLoS One. 5:e87442010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jung S, Ohk J, Jeong D, Li C, Lee S, Duan
J, Kim C, Lim JS, Yang Y, Kim KI, et al: Distinct regulatory effect
of the p34SEI-1 oncoprotein on cancer metastasis in
HER2/neu-positive and -negative cells. Int J Oncol. 45:189–196.
2014.PubMed/NCBI
|
|
31
|
Hong SW, Shin JS, Lee YM, Kim DG, Lee SY,
Yoon DH, Jung SY, Hwang JJ, Lee SJ, Cho DH, et al: p34 (SEI-1)
inhibits ROS-induced cell death through suppression of ASK1. Cancer
Biol Ther. 12:421–426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen S, Rehman SK, Zhang W, Wen A, Yao L
and Zhang J: Autophagy is a therapeutic target in anticancer drug
resistance. Biochim Biophys Acta. 1806:220–229. 2010.PubMed/NCBI
|
|
34
|
Jung S, Li C, Duan J, Lee S, Kim K, Park
Y, Yang Y, Kim KI, Lim JS, Cheon CI, et al: TRIP-Br1 oncoprotein
inhibits autophagy, apoptosis, and necroptosis under
nutrient/serum-deprived condition. Oncotarget. 6:29060–29075.
2015.PubMed/NCBI
|
|
35
|
Jung S, Li C, Jeong D, Lee S, Ohk J, Park
M, Han S, Duan J, Kim C, Yang Y, et al: Oncogenic function of
p34SEI-1 via NEDD4-1-mediated PTEN ubiquitination/degradation and
activation of the PI3K/AKT pathway. Int J Oncol. 43:1587–1595.
2013.PubMed/NCBI
|
|
36
|
Choi EJ, Kim T and Lee MS: Pro-apoptotic
effect and cytotoxicity of genistein and genistin in human ovarian
cancer SK-OV-3 cells. Life Sci. 80:1403–1408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li C, Jung S, Lee S, Jeong D, Yang Y, Kim
KI, Lim JS, Cheon CI, Kim C, Kang YS, et al: Nutrient/serum
starvation derived TRIP-Br3 down-regulation accelerates apoptosis
by destabilizing XIAP. Oncotarget. 6:7522–7535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hayashi R, Goto Y, Ikeda R, Yokoyama KK
and Yoshida K: CDCA4 is an E2F transcription factor family-induced
nuclear factor that regulates E2F-dependent transcriptional
activation and cell proliferation. J Biol Chem. 281:35633–35648.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tategu M, Nakagawa H, Hayashi R and
Yoshida K: Transcriptional co-factor CDCA4 participates in the
regulation of JUN oncogene expression. Biochimie. 90:1515–1522.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bennetts JS, Fowles LF, Berkman JL, van
Bueren KL, Richman JM, Simpson F and Wicking C: Evolutionary
conservation and murine embryonic expression of the gene encoding
the SERTA domain-containing protein CDCA4 (HEPP). Gene.
374:153–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bohensky J, Shapiro IM, Leshinsky S,
Terkhorn SP, Adams CS and Srinivas V: HIF-1 regulation of
chondrocyte apoptosis: Induction of the autophagic pathway.
Autophagy. 3:207–214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pursiheimo JP, Rantanen K, Heikkinen PT,
Johansen T and Jaakkola PM: Hypoxia-activated autophagy accelerates
degradation of SQSTM1/p62. Oncogene. 28:334–344. 2009. View Article : Google Scholar
|
|
43
|
Weidemann A and Johnson RS: Biology of
HIF-1alpha. Cell Death Differ. 15:621–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Greijer AE and van der Wall E: The role of
hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J
Clin Pathol. 57:1009–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
